157 related articles for article (PubMed ID: 21965303)
1. Survival of pancreatic beta cells is partly controlled by a TCF7L2-p53-p53INP1-dependent pathway.
Zhou Y; Zhang E; Berggreen C; Jing X; Osmark P; Lang S; Cilio CM; Göransson O; Groop L; Renström E; Hansson O
Hum Mol Genet; 2012 Jan; 21(1):196-207. PubMed ID: 21965303
[TBL] [Abstract][Full Text] [Related]
2. The LIM homeodomain protein ISL1 mediates the function of TCF7L2 in pancreatic beta cells.
Shao W; Szeto V; Song Z; Tian L; Feng ZP; Nostro MC; Jin T
J Mol Endocrinol; 2018 Jul; 61(1):1-12. PubMed ID: 29678908
[TBL] [Abstract][Full Text] [Related]
3. Transcription factor 7-like 2 regulates beta-cell survival and function in human pancreatic islets.
Shu L; Sauter NS; Schulthess FT; Matveyenko AV; Oberholzer J; Maedler K
Diabetes; 2008 Mar; 57(3):645-53. PubMed ID: 18071026
[TBL] [Abstract][Full Text] [Related]
4. TCF7L2 splice variants have distinct effects on beta-cell turnover and function.
Le Bacquer O; Shu L; Marchand M; Neve B; Paroni F; Kerr Conte J; Pattou F; Froguel P; Maedler K
Hum Mol Genet; 2011 May; 20(10):1906-15. PubMed ID: 21357677
[TBL] [Abstract][Full Text] [Related]
5. HMGB1 binds to the rs7903146 locus in TCF7L2 in human pancreatic islets.
Zhou Y; Oskolkov N; Shcherbina L; Ratti J; Kock KH; Su J; Martin B; Oskolkova MZ; Göransson O; Bacon J; Li W; Bucciarelli S; Cilio C; Brazma A; Thatcher B; Rung J; Wierup N; Renström E; Groop L; Hansson O
Mol Cell Endocrinol; 2016 Jul; 430():138-45. PubMed ID: 26845344
[TBL] [Abstract][Full Text] [Related]
6. TCF7L2 in mouse pancreatic beta cells plays a crucial role in glucose homeostasis by regulating beta cell mass.
Takamoto I; Kubota N; Nakaya K; Kumagai K; Hashimoto S; Kubota T; Inoue M; Kajiwara E; Katsuyama H; Obata A; Sakurai Y; Iwamoto M; Kitamura T; Ueki K; Kadowaki T
Diabetologia; 2014 Mar; 57(3):542-53. PubMed ID: 24317852
[TBL] [Abstract][Full Text] [Related]
7. Chromatin occupancy of transcription factor 7-like 2 (TCF7L2) and its role in hepatic glucose metabolism.
Norton L; Fourcaudot M; Abdul-Ghani MA; Winnier D; Mehta FF; Jenkinson CP; Defronzo RA
Diabetologia; 2011 Dec; 54(12):3132-42. PubMed ID: 21901280
[TBL] [Abstract][Full Text] [Related]
8. TCF7L2 regulates late events in insulin secretion from pancreatic islet beta-cells.
da Silva Xavier G; Loder MK; McDonald A; Tarasov AI; Carzaniga R; Kronenberger K; Barg S; Rutter GA
Diabetes; 2009 Apr; 58(4):894-905. PubMed ID: 19168596
[TBL] [Abstract][Full Text] [Related]
9. TCF7L2 is a master regulator of insulin production and processing.
Zhou Y; Park SY; Su J; Bailey K; Ottosson-Laakso E; Shcherbina L; Oskolkov N; Zhang E; Thevenin T; Fadista J; Bennet H; Vikman P; Wierup N; Fex M; Rung J; Wollheim C; Nobrega M; Renström E; Groop L; Hansson O
Hum Mol Genet; 2014 Dec; 23(24):6419-31. PubMed ID: 25015099
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic Pericytes Support β-Cell Function in a Tcf7l2-Dependent Manner.
Sakhneny L; Rachi E; Epshtein A; Guez HC; Wald-Altman S; Lisnyansky M; Khalifa-Malka L; Hazan A; Baer D; Priel A; Weil M; Landsman L
Diabetes; 2018 Mar; 67(3):437-447. PubMed ID: 29246974
[TBL] [Abstract][Full Text] [Related]
11. Geniposide promotes beta-cell regeneration and survival through regulating β-catenin/TCF7L2 pathway.
Yao DD; Yang L; Wang Y; Liu C; Wei YJ; Jia XB; Yin W; Shu L
Cell Death Dis; 2015 May; 6(5):e1746. PubMed ID: 25950476
[TBL] [Abstract][Full Text] [Related]
12. TCF7L2 rs7903146 impairs islet function and morphology in non-diabetic individuals.
Le Bacquer O; Kerr-Conte J; Gargani S; Delalleau N; Huyvaert M; Gmyr V; Froguel P; Neve B; Pattou F
Diabetologia; 2012 Oct; 55(10):2677-2681. PubMed ID: 22911383
[TBL] [Abstract][Full Text] [Related]
13. Tumor protein p53-induced nuclear protein 1 (TP53INP1) in spontaneous chronic pancreatitis in the WBN/Kob rat: drug effects on its expression in the pancreas.
Jiang PH; Motoo Y; Iovanna JL; Pébusque MJ; Xie MJ; Okada G; Sawabu N
JOP; 2004 Jul; 5(4):205-16. PubMed ID: 15254349
[TBL] [Abstract][Full Text] [Related]
14. MiR-205 is up-regulated in islets of diabetes-susceptible mice and targets the diabetes gene Tcf7l2.
Ouni M; Gottmann P; Westholm E; Schwerbel K; Jähnert M; Stadion M; Rittig K; Vogel H; Schürmann A
Acta Physiol (Oxf); 2021 Aug; 232(4):e13693. PubMed ID: 34028994
[TBL] [Abstract][Full Text] [Related]
15. TCF7L2 controls insulin gene expression and insulin secretion in mature pancreatic beta-cells.
Loder MK; da Silva Xavier G; McDonald A; Rutter GA
Biochem Soc Trans; 2008 Jun; 36(Pt 3):357-9. PubMed ID: 18481957
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic alpha cell-selective deletion of Tcf7l2 impairs glucagon secretion and counter-regulatory responses to hypoglycaemia in mice.
da Silva Xavier G; Mondragon A; Mourougavelou V; Cruciani-Guglielmacci C; Denom J; Herrera PL; Magnan C; Rutter GA
Diabetologia; 2017 Jun; 60(6):1043-1050. PubMed ID: 28343277
[TBL] [Abstract][Full Text] [Related]
17. Transcription factor-7-like 2 (
Nguyen-Tu MS; da Silva Xavier G; Leclerc I; Rutter GA
J Biol Chem; 2018 Sep; 293(36):14178-14189. PubMed ID: 29967064
[TBL] [Abstract][Full Text] [Related]
18. Chikusetsu saponin IVa protects pancreatic β cell against intermittent high glucose-induced injury by activating Wnt/β-catenin/TCF7L2 pathway.
Cui J; Duan J; Chu J; Guo C; Xi M; Li Y; Weng Y; Wei G; Yin Y; Wen A; Qiao B
Aging (Albany NY); 2020 Jan; 12(2):1591-1609. PubMed ID: 31969494
[TBL] [Abstract][Full Text] [Related]
19. The type 2 diabetes presumed causal variant within TCF7L2 resides in an element that controls the expression of ACSL5.
Xia Q; Chesi A; Manduchi E; Johnston BT; Lu S; Leonard ME; Parlin UW; Rappaport EF; Huang P; Wells AD; Blobel GA; Johnson ME; Grant SFA
Diabetologia; 2016 Nov; 59(11):2360-2368. PubMed ID: 27539148
[TBL] [Abstract][Full Text] [Related]
20. In vitro scan for enhancers at the TCF7L2 locus.
Savic D; Park SY; Bailey KA; Bell GI; Nobrega MA
Diabetologia; 2013 Jan; 56(1):121-5. PubMed ID: 23011354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
